New insulin copycat tested in healthy people – no cure, just comparison
Knowledge-focused
Completed
This study tested whether a new rapid-acting insulin (I004) works the same as the approved insulin NovoLog. Sixty-nine healthy adults received single doses of both insulins in a blinded, crossover design. The goal was to measure how the body absorbs and responds to each insulin, …
Phase: PHASE2, PHASE3 • Sponsor: Amphastar Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC